Optomed’s January-September 2023 interim report will be published on 3 November 2023

Optomed Plc Press Release 30 October 2023 at 10.00, Helsinki

Optomed’s January-September 2023 interim report will be published on 3 November 2023

Optomed will publish its January-September 2023 interim report on 3 November 2023 approximately at 9.00 EET.

A telephone conference for analysts, investors and media will be arranged on the publishing day at 11.00 EET/10.00 CET. The event will be held in English. The presentation material will be available at www.optomed.com/investors 10.00 EET at the latest.

The participants are requested to register for the call in advance by email to sakari.knuutti@optomed.com.

Please see the call-in numbers below:

FI +358 9 8562 6300

FR +33 1 70 99 53 92

SE +46 8 505 218 52

UK +44 20 3321 5273

US +1 646 838 1719

The conference id is 197 712 168#.

Please note that by dialling in to the conference call, the participant agrees that personal information such as name and company name will be collected.

Optomed Plc

Further enquiries

Sakari Knuutti, CFO, Optomed Plc, sakari.knuutti@optomed.com, +358 50 562 4077

Optomed in Brief 

Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye diseases, such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries.